Bromocriptine Suppliers UK
Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
Product | Description | |
---|---|---|
Bromocriptine Quick enquiry Where to buy Suppliers range | Bromocriptine, an ergoline derivative, is a dopamine agonist. It is used in the treatment of pituitary tumors, Parkinson's disease (PD), hyperprolactinaemia, neuroleptic malignant syndrome, and type 2 diabetes. Group: Pharmaceuticals. Alternative Names: (5'-a2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3'; 2-bromo-alpha-ergocryptine; 2-bromo-alpha-ergokryptin; 2-bromo-alpha-ergokryptine; 2-bromoergocryptine; (5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-ergotama. CAS No. 25614-03-3. Pack Sizes: 1mg; 1g; 10g. Product ID: 25614-03-3. Custom synthesis is available. Send your inquiries for more information. | London |
Bromocriptine Impurity B Quick enquiry Where to buy Suppliers range | Bromocriptine Impurity B is an ergopeptine and one of the ergot alkaloids. It is an impurity of 2-Bromo α-Ergocryptine Mesylate. Group: Pharmaceuticals. Alternative Names: α-Ergocryptine; (5'α)-12'-Hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; Ergokryptine; NSC 169479. CAS No. 511-09-1. Pack Sizes: 1mg; 1g; 10g. Product ID: 511-09-1. Custom synthesis is available. Send your inquiries for more information. | London |
Cabergoline Quick enquiry Where to buy Suppliers range | Cabergoline is a lysergic acid amide derivative and a potent dopamine D2 receptor agonist. It has been used for monotherapy of Parkinson's disease in the early phase. It has a direct inhibitory effect on pituitary lactotroph (prolactin) cells. It acts on dopamine receptors in lactophilic hypothalamus cells to suppress prolactin production in the pituitary gland. It has been used as a first-line agent in the management of prolactinomas due to its higher affinity for D2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine. It is developed by Johnson & Johnson. It has been approved the listing. Uses: Cabergoline has been used for monotherapy of Parkinson's disease in the early phase. It has been used as a first-line agent in the management of prolactinomas. Group: Pharmaceuticals. Alternative Names: Cabergoline; CG-101; FCE-21336; CG 101; FCE 21336; CG101; FCE21336; Cabaser; Cabaseril; (6aR, 9R, 10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6, 6a, 8, 9, 10, 10a-hexahydro-4H-indolo[4, 3-fg]quinoline-9-carboxamide; 6-Allyl-n-[3-(dimethylamino)propyl]-n-(ethylcarbamoyl)ergoline-8-carboxamide; (8-Beta)-(2-propenyl); n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-ergoline-8-carboxamid; FCE-21336, Cabaser, Dostinex; Cabaseril; Cabergolinum; (8β )-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)-ergoline-8-carboxamide. CAS No. 81409-90-7. Pack Sizes: 1mg; 1g; 10g. Product ID: 81409-90-7. Custom synthesis is available. Send your inquiries for more information. | London |